MiR-34a/SIRT1 Axis Modulating Therapeutic Effect of Olaparib on Pancreatic Cancer through Suppressing PARP1 and EMT

被引:0
|
作者
Liu, Linxun [1 ]
Deng, Rubing [2 ]
Yang, Jinyu [1 ]
Ye, Chengjie [1 ]
Yang, Pei [3 ]
Zhang, LingFeng [4 ]
Shen, Binbin [5 ]
机构
[1] Qinghai Prov Peoples Hosp, Dept Gen Surg, Xining 810000, Qinghai, Peoples R China
[2] Sichuan Univ, Peoples Hosp Longquanyi Dist 1, Gen Surg Dept, ChengduyWest China Longquan Hosp, Chengdu, Sichuan, Peoples R China
[3] Mianyang Cent Hosp, Dept Hepatobiliary Surg, Mianyang 621000, Sichuan, Peoples R China
[4] First Peoples Hosp Huaihua City, Dept Hepatobiliary Surg, Huaihua 418000, Hunan, Peoples R China
[5] Jiaxing Univ, Dept Gen Surg, Affiliated Hosp, Jiaxing 314000, Zhejiang, Peoples R China
关键词
Epithelial-mesenchymal Transition; MicroRNA-34a; Olaparib; Poly-ADP-ribose Polymerase 1; Sirtuin; 1; EPIDEMIOLOGY; GEMCITABINE; SIRT1;
D O I
10.3109/24566330.2021/21.02.775
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study analyzed functions of miR-34a and SIRT1 in modulating efficacy of Olaparib in pancreatic cancer in vitro. RNA expressions of miR-34a and SIRT1 were evaluated through RT-qPCR in HPDE6-C7, SW1990, PANC-1 and MIA PaCa-2 cells. MiR-34a was promoted in cancer cell lines while SIRT1 was decreased. Luciferase reporter assay verified bindings between miR-34a and SIRT1. Moreover, E-cadherin was promoted by miR-34a mimics and SIRT1 suppression while N-cadherin and Vimentin were both downregulated. Additionally, PARP1 protein expression was increased after miR-34a promotion and SIRT1 downregulation. Besides that, PARP1 protein levels and EMT were significantly inhibited after treated by Olaparib (0, 0.5, 1 and 1.5 mu M). In Olaparib-treated cancer cells, SIRT1, PARP1 and EMT were all distinctly decreased after SIRT1 suppression and overexpression of miR-34a induced much lower level of SIRT1.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 50 条
  • [1] The NAD+/PARP1/SIRT1 Axis in Aging
    Mendelsohn, Andrew R.
    Larrick, James W.
    REJUVENATION RESEARCH, 2017, 20 (03) : 244 - 247
  • [2] miR-34a repression of SIRT1 regulates apoptosis
    Yamakuchi, Munekazu
    Ferlito, Marcella
    Lowenstein, Charles J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (36) : 13421 - 13426
  • [3] CO ameliorates cellular senescence and aging by modulating the miR-34a/Sirt1 pathway
    Park, Jeongmin
    Kim, Jin
    Chen, Yingqing
    Song, Hyun-Chul
    Chen, Yubing
    Zheng, Min
    Surh, Young-Joon
    Kim, Uh-Hyun
    Park, Jeong Woo
    Joe, Yeonsoo
    Chung, Hun Taeg
    FREE RADICAL RESEARCH, 2020, 54 (11-12) : 848 - 858
  • [4] LncRNA MNX1-AS1 contributes to lung adenocarcinoma progression by targeting the miR-34a/SIRT1 axis
    Liu, Gaofeng
    Zhang, Yong
    Zhang, Xiaozhen
    Liu, Yan
    Xu, Yanbin
    Cui, Sujuan
    Li, Gang
    Wang, Jianjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4977 - 4989
  • [5] miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression
    Duan, Kun
    Ge, Yong-Chao
    Zhang, Xue-Pei
    Wu, Shu-Yi
    Feng, Jin-Shun
    Chen, Shi-Lin
    Zhang, Li
    Yuan, Zhi-Hao
    Fu, Chao-Hong
    ONCOLOGY LETTERS, 2015, 10 (05) : 3223 - 3227
  • [6] MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1
    Liu, Yang
    Li, Qinshan
    Liang, Huiling
    Xiang, Miaomiao
    Tang, Dongxin
    Huang, Mei
    Tao, Yixi
    Ren, Min
    Zhao, Mei
    Wang, Jishi
    Shu, Liping
    He, Zhixu
    Wang, Feiqing
    Li, Yanju
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [7] Trans-chalcone enhances insulin sensitivity through the miR-34a/SIRT1 pathway
    Karimi-Sales, Elham
    Jeddi, Sajad
    Ebrahimi-Kalan, Abbas
    Alipour, Mohammad Reza
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 21 (04) : 359 - 363
  • [8] Metformin inhibits high glucose-induced apoptosis of renal podocyte through regulating miR-34a/SIRT1 axis
    Zhuang, Xudong
    Sun, Zhuye
    Du, Huasheng
    Zhou, Tianhui
    Zou, Jing
    Fu, Wei
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (01)
  • [9] Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway
    Kim, Hyo Jeong
    Joe, Yeonsoo
    Yu, Jae Kyoung
    Chen, Yingqing
    Jeong, Sun Oh
    Mani, Nithya
    Cho, Gyeong Jae
    Pae, Hyun-Ock
    Ryter, Stefan W.
    Chung, Hun Taeg
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (07): : 1550 - 1559
  • [10] miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis
    Meng, Fanyi
    Yang, Man
    Chen, Yinshuang
    Chen, Weichang
    Wang, Weipeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2247 - 2259